Business

Two coronavirus vaccines begin the last phase of testing: 30,000-person trials

The vaccination marks a much-anticipated milestone: the official launch of the first in a series of large U.S. clinical trials that will each test experimental vaccines in 30,000 participants, half r…
Read More

Show More

Related Articles

Back to top button
Close
Close